home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences
Search  -  prev / next
 
 

2nd Annual Genome Editing USA Congress

 
  November 16, 2017  
     
 
Oxford Global Conferences, Boston, USA
10th - 11th May 2018


2nd Annual Genome Editing USA Congress will be held on 10 – 11 May 2018 in Boston. Co-located with Transgenic Technologies as well as Synthetic Biology Congresses, the events bring together over 300 senior level attendees from academia, research institutes and pharma companies.

 

Over 20 presentations dedicated to genome editing technologies and the applications of genome editing in a range of therapeutic areas, including CNS disease, oncology and genetic disorders. We will also be addressing the key updates in drug discovery and development, including bioinformatics and target identification. Over the two days the event will be split into 3 interactive streams:

  • Genome Editing Techniques
  • Therapeutic Applications of Genome Editing
  • Drug Discovery & Development Applications
 
 
Organized by: OxfordGlobal
Invited Speakers:

Rodger Novak, Chief Executive Officer
CRISPR Therapeutics

Tod Woolf, Founder and President
ETAGEN Pharma

Katherine Pawelczak, Vice President of Research
NERx Biosciences

John Feder, Associate Director, Genome Biology & Emerging Technologies
Bristol-Myers Squibb

Glenn Cowley, Global Head of Functional Genomics
Janssen Pharmaceutical Companies of Johnson & Johnson

Benjamin Haley, Group Leader and Senior Scientist
Genentech

Danilo Maddalo, Lab Head, Oncology Division
Novartis Institutes for Biomedical Research

Tara Moore, Professor of Personalised Medicine and Director, Biomedical Science Research Institute (BMSRI)
University of Ulster

Rudolf Jaenisch, Professor of Biology
Whitehead Institute for Biomedical Research

Clifford Steer, Professor of Medicine and Genetics, Cell Biology, and Development; Director, Molecular Gastroenterology Program
University of Minnesota Medical School

Christof von Kalle, Professor and Director
National Center for Tumor Diseases Heidelberg

Eric Hendrickson, Professor, Biochemistry, Molecular Biology, and Biophysics
University of Minnesota

Guangping Gao, Professor, Microbiology & Physiological Systems
University of Massachusetts Medical School

Luciano del Priore, Professor
Yale University

Niren Murthy, Professor
University of California, Berkeley

Norbert Perrimon, Professor
Harvard Medical School

Cristopher Bragg, Director of Research for the Collaborative Center for X-linked Dystonia Parkinsonism
Massachusetts General Hospital

Kai Wucherpfennig, Director, Center for Cancer Immunotherapy Research
Dana-Farber Cancer Institute

Pradeep Mammen, Director: Translational Research for the Advanced Heart Failure and Transplant Cardiology Program
UT Southwestern Medical Center

Aimee Stablewski, Co-Director, Gene Targeting And Transgenic Resource
Roswell Park Cancer Institute

Laura Lambert, Assistant Director, TGEM’s
University of Alabama at Birmingham

Jonathan Zirin, Assistant Director of DRSC/TRiP-FGR
Harvard Medical School

Guillaume Lambert, Principal Investigator
Cornell University

Richard Frock, Associate Professor and Research Fellow
Boston Children’s Hospital

Pablo Perez-Pinera, Associate Professor
University of Illinois at Urbana-Champaign

Richard Sherwood, Instructor of Medicine
Brigham and Women’s Hospital

 
Deadline for Abstracts: N/A
 
Registration:

https://ds3.delegateselect.com/MT/Run/event/main.html?EC=ox805031&EEID=137219775116907046602491995&EGID=971352320&override=shownewreg

E-mail: g.alonso@oxfordglobal.co.uk
 
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2018 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.